期刊文献+

VEGF,Clusterin在乳腺癌组织中的表达及其意义 被引量:2

下载PDF
导出
摘要 目的探讨血管内皮生长因子(vascular endothelial growth factor,VEGF)和凋亡相关因子Clusterin在乳腺癌组织中的表达及其意义。方法采用免疫组化SP法检测乳腺癌组织和癌周正常组织中VEGF和Clusterin的表达情况,并分析其临床病理意义。结果VEGF在正常乳腺组织中表达率为44%(44/100),在乳腺癌组织中的表达率为91%(91/100),Clusterin在正常乳腺组织中表达率为10%(10/100),在乳腺癌组织中的表达率为77%(77/100)。VEGF表达水平与乳腺癌TNM分期、淋巴结转移有关(P<0.01),Clusterin表达水平与与乳腺癌肿瘤组织学分型、组织学分级、TNM分期、淋巴结转移有关(P<0.05)。结论VEGF、Clusterin的表达在乳腺癌的发生、发展过程中起重要作用,同时检测VEGF和Clusterin有利于评估乳腺癌的生物学行为和判断乳腺癌预后。
出处 《广东医学》 CAS CSCD 北大核心 2009年第8期1152-1154,共3页 Guangdong Medical Journal
  • 相关文献

参考文献6

  • 1TAMMELA T, ENHOLM B, ALITALO K, et al. The biology of vascular endothelial growth factor[J]. Cardiovasc Res, 2005, 65 (3) : 550 -563.
  • 2梁启廉,陈小东,王三明,李建文,黄冰,许燕云,陈雪松.VEGF和metastin在大肠癌组织中的表达[J].南方医科大学学报,2007,27(10):1584-1587. 被引量:15
  • 3TROUGAKOS I P, GONOS E S. Clusterin/apolipoprotein j in human aging and cancer [ J ]. Int J Biochem Cell Biol, 2002, 34 (11): 1 430-1 448.
  • 4SHAROU M, JOSEPH S S, JANMES M, et al. Cytotoxic sensitivity to tumor necrosis factor - alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular Levels of SGP - 2 ( Clusterin) [J]. Prostate, 1999, 39(2) : 87 -93.
  • 5TROUGAKOS I P, SO A, JANSEN B, et al. Silencing expression of the clusterin/apolipoprotein gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress[J]. Cancer Res, 2004, 64(5): 1 834-1 842.
  • 6KRUGER S, OLA V, FISCHER D, et al. Prognostic significance of clusterin immunoreactivity in breast cancer[ J]. 2007, 54( 1 ) : 46 - 50.

二级参考文献8

  • 1Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells [ J ]. Biochem Biophys Res Commun, 1989, 161 (2): 851-8.
  • 2Tammela T, Enholm B, Alitalo K, et al. The biology of vascular endothelial growth factor [J]. Cardiovasc Res, 2005, 65(3): 550-63.
  • 3Asano M, Yukita A, Suzuki H, et al. Wide Spectrum of antitumor activity of neutralizing monoclonal antibody to human vascular endothelial growth factor[J]. Jpn J Cancer Res, 1999, 90(1): 93-100.
  • 4Chen Hx, Mooney M, Boron M, et al. Phase Ⅱ multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301 [ J ]. J Clin Oncol, 2006, 24(21): 3354-60.
  • 5Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene [J ]. J Natl Cancer Inst, 1996, 88(23): 1731-37.
  • 6Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-I expression is associated with bladder cancer progression and clinical outcome [ J ]. Am J Pathol, 2003, 162(2): 609-17.
  • 7Stark AM, Tongers K, MaassN, et al. Reduced metastasis-suppressor gene Mma-expression in breast cancer brain metastases [ J ]. J Cancer Res Clin Oncol, 2005, 131 (3) : 191 -8.
  • 8Dhar DK, Naom H, Kubota H, et al. Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma [ J ]. lnt J Cancer, 2004, 315( 1): 85-92.

共引文献14

同被引文献30

  • 1张学东,王新杰.老年人大肠癌特点分析[J].中国临床医生杂志,2004,32(9):27-28. 被引量:1
  • 2高健群,易少波.P^(16)和P^(53)蛋白在大肠癌中的表达及其临床意义[J].中国医刊,2004,39(12):39-40. 被引量:2
  • 3张珊文.抑癌基因p53治疗恶性肿瘤的基础与临床研究[J].武警医学,2007,18(4):245-248. 被引量:5
  • 4Zadrozny M,Smolarz B,Romanowicz-Makowska H,etal.Genetic analysis of HER-2/neu gene amplification inparaffin embedded tumour tissue in women with breast can-cer[J].Pol J Pathol,2002,53(4):189-193.
  • 5Bollig A,Miksicek R J.An estrogen receptor-alpha splic-ing variant mediates both positive and negative effects ongene transcription[J].Mol Endocrinol,2000,14(5):634-649.
  • 6Gwinn M R,Leonard S S,Sargent L M,et al.The role ofp53 in silica-induced cellular and molecular responses asso-ciated with carcinogenesis[J].J Toxicol Environ Health A,2009,72(23):1509-1519.
  • 7Ranade K J,Nerurkar A V,Phulpagar M D,et al.Ex-pression of survivin and p53 proteins and their correlationwith hormone receptor status in Indian breast cancer pa-tients[J].Indian J Med Sci,2009,63(11):481-490.
  • 8Mao B,Wu W,Davidson G,et al.Kremen proteins areDickkopf receptors that regulate Wnt/beta-catenin sig-nalling[J].Nature,2002,417(6889):664-667.
  • 9Mao B,WuW,LiY,et al.LDL-receptor-relatedpro-tein 6 is a receptor for Dickkopf proteins[J].Nature,2001,411(6835):321-325.
  • 10Bafico A,Liu G,Yaniv A,et al.Novel mechanism ofWnt signalling inhibition mediatedby Dickkopf-1 interac-tion with LRP6/Arrow[J].Nat Cell Biol,2001,3(7):683-686.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部